@lisayentwin Profile picture

Lisa Yen

@lisayentwin

LACNETS Director of Programs & Outreach. @LACNETS. Former NP Hospitalist turned NET caregiver and NET advocate. NBC-HWC - train/mentor HCPs. Tweets mine.

Similar User
NANETS photo

@NANETS1

LACNETS photo

@LACNETS

NET CONNECT photo

@net_connectinfo

Thor Halfdanarson photo

@OncoThor

Aman Chauhan photo

@AmanChauhanMD

Jaydira Del Rivero, MD photo

@JaydiDelRivero

World Neuroendocrine Cancer Day #WNCD photo

@World_WNCD

Hagen Kennecke photo

@HKennecke

Jessica Thomas, MSW, LCSW photo

@jsalinisthomas

Tanaz Vaghaiwalla, MD MS photo

@TVaghaiwalla

NCAN photo

@netcanceraware

Heloisa Soares MD photo

@helops79

Chandrikha Chandrasekharan photo

@ChandrikhaC

Rachael Guenter, PhD photo

@rachaelguenter

Satya (Nanu) Das photo

@nanudasmd

Excellent presentation! There needs to be more awareness of palliative care and how it can help patients & their families. @CarcinoidNETs @netcancerday @HealingNET1 @CureNETs #LetsTalkAboutNET

In case you missed it, watch "Palliative Care for Neuroendocrine Tumors" with Dr. Banerjee at youtu.be/FiYogD5g_9A. Help us improve our programs by taking a survey at forms.gle/hoBtriCaxjgPYn…. #lacnets #NeuroendocrineCancer #palliativecare

Tweet Image 1


What a memorable day! Thanks to all who attended & supported our @LACNETS NCD Symposium! #LetsTalkAboutNET

On November 9th, LACNETS held its 2024 NET Cancer Day Symposium in Santa Monica, California, to recognize and celebrate World #NETCancerDay. 80 people gathered to learn from renowned physicians, sponsors, and to connect with one another. Check our blog post for more…

Tweet Image 1
Tweet Image 2
Tweet Image 3


Happy heavenly birthday to our dear friend Giovanna. We are grateful for the legacy she’s created with @LACNETS Please help us continue to carry on her vision.

On November 9th, we celebrate the birthday of our late founder, Giovanna Joyce Imbesi. In 2020, the Vision Fund was established in memory of Giovanna, whose vision was to empower NET patients and caregivers so they may live richly and fully. ​Her tireless work resulted in what…

Tweet Image 1


What a special day! Thank you for all who joined us in person or in spirit! 🙏❤️

We are so pleased to host the 2024 #NETCancerDay Symposium in Santa Monica today! Thanks to our incredible speakers: @AGangiMD, Martin Auerbach, @JaydiDelRivero, @DrHendifar, Dr. Run Yu & Stephanie Alband. Many thanks to our sponsors: @Novartis, @IpsenUS, @Crinetics,…

Tweet Image 1


Why is an Icelander in Spain?! 🇪🇸 @OncoThor explains!

NET expert at Mayo Clinic, Dr. Thor Halfdanarson, shared the importance of @INCA's 12th annual Global NET Patient Advocate Summit in Spain: youtu.be/0GI4slazkug Read more at: lacnets.org/post/patient-a… @NANETS1 @netcancerday @HealingNET1 #LetsTalkAboutNETs



Happy to be here representing @LACNETS and seeing many friends here!

Thankful to see @lisayentwin at The Ninth Bay Area Neuroendocrine Patient Conference - Hosted by UCSF and NorCal CarciNET Community. @CureNETs @LACNETS

Tweet Image 1


Thanks @NANETS1 @OncoThor @cancerassassin1 @PatrickMcGarrah @DonnaDSouzaMD @ChandrikhaC Ajay Prakash & Philip Boudreaux and the patient panel and all who attended!

Many thanks to the attendees, speakers, and supporters for joining us for an afternoon of learning and connecting on Sep 21st in Minneapolis! Read more about the Regional LACNETS Educational Event at lacnets.org/post/lacnets-h….

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Watch Dr Chan explain what the updated results of the CABINET trial shows & what it means. Full transcript also available: lacnets.org/post/positive-@NANETS1 @myESMO @netcancerday @ALLIANCE_org @CureNETs @HealingNET1 @net_connectinfo

Incoming NANETS president Dr. Chan discusses the updated results of the CABINET trial evaluating Cabozantinib as a new, effective treatment for Advanced Neuroendocrine Tumors. Watch youtu.be/4iWtw3qmrBs @NANETS1 @myESMO @ALLIANCE_org @DanaFarber @NETCancerDay



It was an honor to interview @maryam_lustberg and hear her insights and tips about supportive care for #NET patients. @NANETS1 @netcancerday @CureNETs @HealingNET1 @PheoPara #LetsTalkAboutNETs

📻 New podcast episode 'Supportive Oncology for Neuroendocrine Cancer' is now available. ➡️Visit lacnets.org/podcast/37 Dr. Lustberg suggests strategies to manage cancer-related fatigue, diarrhea, nausea, mouth sores, peripheral neuropathy, distress, and anxiety. #LACNETS

Tweet Image 1


Congrats Dr Jen Chan & all the investigators & collaborators! Look forward to having another treatment in the toolbox for NET patients of all primary sites & grades that works even after taking previous treatments.

#ESMO24: Jen Chan, MD gives an excellent sequel to her #ESMO23 presentation of the promising CABINET trial results with updated results of PFS by blinded independent review. ➡️Subgroup analysis shows benefits for Cabo across tumor sites & grades ➡️Consider for pts who have had…

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4


Look who I happened to sit with at #ESMO24 just after reading the news release! Dr Delpassand treated my husband in 2016 with Lu177 dotatate x4 prior to its FDA approval. Congrats @OranoMed @RadioMedix @sanofi Thank you for your efforts in providing NET therapies!

Tweet Image 1

#NEWS: Today, we’ve entered into an exclusive licensing agreement with @OranoMed and @RadioMedix, to advance a next-generation medicine, now in Phase 2, in the expanding field of radioligand therapies. Learn more ⬇️



Just learned about FORCE (InFrastructure fOr Rare Cancers in the NEtherlands) by @NCkanker INCA24 earlier this week. Now again @myESMO #ESMO24 by @1969yolo Interesting project to watch! 👀

Tweet Image 1
Tweet Image 2

#ESMO24 Here bright & early for Day 2! @myESMO @LACNETS @JaydiDelRivero

Tweet Image 1

Lisa Yen Reposted

#ESMO24: Dr Marianne Pavel presented more data from NETTER2. Nothing new, but good to know results are reliable & consistent. Now, we wait for OS & late toxicity results & COMPOSE trial to give more info about sequencing. @netcancerday @NANETS1 @CureNETs @net_connectinfo

Tweet Image 1
Tweet Image 2
Tweet Image 3

Lisa Yen Reposted

#ESMO24: Novel #NET therapy presentation with first in class TARP inhibitor. Imperfect trial but very interesting d/t tolerability & activity. Perhaps worth another look as we are always seeking other options using different mechanisms for NETs?? @NANETS1 @CureNETs @HealingNET1

1st #Neuroendocrine presentation at #ESMO2024 is by Dr Chia-Jui Yen from Taiwan. Happy to see the efforts & innovation from my home country! 🇹🇼 @LACNETS @JaydiDelRivero

Tweet Image 1


Lisa Yen Reposted

LACNETS Director of Programs & Outreach, Lisa Yen, is at the 2024 INCA Global NET Summit in Segovia where she presented NET VITALS as an example of best practices & challenges in working with the medical community. Check out NET VITALS here: lacnets.org/netvitals @netcancerday

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Lisa Yen Reposted

2024 INCA Summit: @NANETS1 President @OncoThor gave a thoughtful talk on meaningful involvement of pts in #NET research. With ⬆️ incidence, there is ⬆️ need & opportunities. NET pt advocacy orgs would love to help! @netcancerday @CureNETs @Globeseek @HealingNET1 @PheoPara

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Oops! I messed up the hashtags 🤦‍♀️ #ESMO24 @myESMO


Loading...

Something went wrong.


Something went wrong.